Semaglutide Synthesis Using Alloc Deprotection and Pd Catalyst
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing Semaglutide face challenges with the removal of protecting groups like Mmt, Mtt, Dde, and ivDde, which require repeated acidic treatments, leading to side reactions, reduced yield, and increased production costs, and the use of hydrazine poses safety hazards in scale-up production.
Innovation Solution
The method employs Fmoc-Lys(Alloc)-OH with Pd(PPh3)4 for deprotection, using Boc-His(Trt)-OH and Boc-His(Boc)-OH.DCHA to minimize racemization and His impurities, and incorporates a side chain fragment for enhanced synthesis efficiency, reducing the number of coupling steps and avoiding the risks associated with acidic treatments and hydrazine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Mmt and Mtt protecting groups are used for Lys, then orthogonal protection is achieved, but repeated acidic treatments (6-12 times) are required for deprotection, causing side reactions and reducing yield
Solution Approach 1:
The patent changes the protecting group from Mmt/Mtt to Alloc, which fundamentally alters the deprotection mechanism from acid-cleavable to Pd(0)-cleavable. This parameter change in the protecting group's chemical sensitivity allows single-step deprotection without repeated acidic treatments, thereby preventing side reactions and improving synthesis yield while maintaining orthogonal protection capability
Solution Approach 2:
The patent substitutes the acid-cleavage mechanism with a Pd(0)-mediated deprotection mechanism. Instead of using repeated acidic treatments to remove protecting groups, the invention employs Pd(PPh3)4 catalyst with morpholine or phenylsilane to cleanly remove Alloc groups in a single step, eliminating the need for multiple acid washes and reducing side reactions
2Ease of manufacture
If Dde or ivDde protecting groups are used for Lys, then deprotection is achieved, but hydrazine solution is required, which has strong reductibility and poses safety hazards in scale-up production
Solution Approach 1:
The patent changes the protecting group from Dde/ivDde to Alloc, which fundamentally alters the deprotection chemistry. Alloc groups are removed by Pd(0) complexes with morpholine or phenylsilane, completely eliminating the need for hydrazine solution. This parameter change maintains deprotection capability while removing the safety hazards associated with hydrazine's strong reductibility and explosive potential
Solution Approach 2:
The patent converts the potential harm of using hazardous hydrazine into a benefit by selecting Alloc protecting groups that can be removed by safe, mild Pd(0)-mediated deprotection. The harmful hydrazine is completely replaced with safe reagents (morpholine or phenylsilane) and a catalytic amount of Pd(PPh3)4, transforming a dangerous process into a safe one while maintaining deprotection effectiveness
3Ease of operation
If weak acid is used for deprotection with 2-CTC resin, then Lys protecting groups are removed, but the linker falls off and polypeptide fragment is cleaved, greatly reducing final yield
Solution Approach 1:
The patent substitutes acid-cleavage-based deprotection with Pd(0)-mediated deprotection. Instead of using weak acid that causes linker cleavage, the invention employs Pd(PPh3)4 catalyst with morpholine or phenylsilane to selectively remove Alloc groups without affecting the acid-labile Wang or 2-CTC resin linkers. This mechanism substitution enables simple single-step deprotection while preventing linker fall-off and maintaining high final yield
Solution Approach 2:
The patent introduces Pd(PPh3)4 as an intermediary catalyst that mediates the deprotection process. The Pd(0) complex acts as a selective intermediary that recognizes and removes Alloc protecting groups without triggering acid-cleavage of the resin linker. This intermediary enables deprotection to proceed under mild, non-acidic conditions, preventing linker fall-off while maintaining operational simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the deprotection process, increases synthesis efficiency, and improves yield and purity, with the crude peptide synthesis yield reaching 93% and refined peptide purity exceeding 99%, while ensuring safer and more economical production.
Implementation Method 1
Pd(PPh3)4 is selected for deprotection
Implementation Method 2
coupling Gly to a resin by solid phase synthesis to obtain Gly-resin; and step 2: successively coupling the Gly-resin prepared in step 1 to an amino acid according to the sequence of the Semaglutide by sequential coupling
Data Source
Figure 1
Figure 2
Figure 3~4
AI summary
A method for preparing Sermaglutide. Amino acid protected by Fmoc-Lys(Alloc)-OH is used as a raw material, and protection is carried out by selecting Pd(PPh3)4. In one aspect, the operation process is simple, one or two times of elimination reactions are required only, each time lasts 10 min to 30 min, and no side reaction occurs, and the operation process is safe, so that the preparation method is suitable for expanding production. The risk of His racemization can be reduced to the greatest extent in the process by using Boc-His(Boc)-OH.DCHA and Boc-His(Trt)-OH as raw materials. The synthesis efficiency is improved by performing coupling by using special segments.